Hester van de Bovenkamp

Hester van de Bovenkamp

Auto-generated profile, based on publicly available information

Hester van de Bovenkamp

Erasmus University Rotterdam

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2015 in International Review of Administrative Sciences
Verified
Journal Article
Open access
FVFemke D. Vennik
Femke D. Vennik
HBHester M. van de Bovenkamp
Hester M. van de Bovenkamp
KPKim Putters
Kim Putters
KGKor J. Grit
Kor J. Grit
Co-production in healthcare is receiving increasing attention; however, insight into the process of co-production is scarce. This article explores why hospitals involve patients and staff in co-production activities and hospitals’ experiences with co-production in practice. A qualitative study with semi-structured interviews ( N = 27), observations (70 hours) and document analysis was conducted in five Dutch hospitals, which involved patients and staff in order to improve services. The results show that hospitals have different motives to involve patients and staff and have adapted existing methods to involve patients. Interestingly, areas of improvement proposed by patients were often already known. However, the process of co-production did contribute to quality improvement in other ways. The process of co-production stimulated hospitals’ thinking about how to realize quality improvements. Quality improvements were facilitated by this process as seeing patients and hearing their experiences created a sense of urgency among staff to act on the improvement issues raised. Moreover, the experiences served to legitimatize improvements to higher management bodies. Points for practitioners: Different participation methods can bring patients’ experiences with healthcare services to the fore, which can be used for quality improvement. Our study shows that adapting existing methods to local hospital resources is likely to be beneficial for co-production processes within a given context. However, adapting and tailoring also poses risks. Tailoring activities, such as using criteria to select patients, influence what is considered to be legitimate patient input. In addition, as the co-production process is important, the method should consist of an organized trajectory in which patients and staff are involved and personal experiences are presented. Therefore, project teams need to critically reflect on the consequences of adaptations and tailoring actions, and their desirability, when carrying out quality improvement projects.

17 February 2010 in Health Expectations
Verified
Journal Article
Closed access
PDF file
HBHester M Van De Bovenkamp
Hester M Van De Bovenkamp
MTMargo J Trappenburg
Margo J Trappenburg
KGKor J Grit
Kor J Grit

20 December 2008 in Health Care Analysis
Verified
Journal Article
Open access
PDF file
HBHester M. van de Bovenkamp
Hester M. van de Bovenkamp
MTMargo J. Trappenburg
Margo J. Trappenburg
Health care has become increasingly patient-centred and medical guidelines are considered to be one of the instruments that contribute towards making it so. We reviewed the literature to identify studies on this subject. Both normative and empirical studies were analysed. Many studies recommend active patient participation in the process of guideline development as the instrument to make guidelines more patient-centred. This is done on the assumption that active patient participation will enhance the quality of the guidelines. We found no empirical evidence, however, to support this assumption. Moreover, the studies show that patients experience several difficulties in the participation process, which cannot solely be traced back to flawed practices. Given this poor track record we conclude that the plea to actively involve patients in the guideline development process should be reconsidered.

2 May 2013 in Health Expectations
Verified
Journal Article
Open access
PDF file
HBHester M. van de Bovenkamp
Hester M. van de Bovenkamp
TZTeun Zuiderent‐Jerak
Teun Zuiderent‐Jerak
Background: Patient participation on both the individual and the collective level attracts broad attention from policy makers and researchers. Participation is expected to make decision making more democratic and increase the quality of decisions, but empirical evidence for this remains wanting.Objective: To study why problems arise in participation practice and to think critically about the consequence for future participation practices. We contribute to this discussion by looking at patient participation in guideline development.Methods: Dutch guidelines (n = 62) were analysed using an extended version of the AGREE instrument. In addition, semi‐structured interviews were conducted with actors involved in guideline development (n = 25).Results: The guidelines analysed generally scored low on the item of patient participation. The interviews provided us with important information on why this is the case. Although some respondents point out the added value of participation, many report on difficulties in the participation practice. Patient experiences sit uncomfortably with the EBM structure of guideline development. Moreover, patients who develop epistemic credibility needed to participate in evidence‐based guideline development lose credibility as representatives for ‘true’ patients.Discussion and conclusions: We conclude that other options may increase the quality of care for patients by paying attention to their (individual) experiences. It will mean that patients are not present at every decision‐making table in health care, which may produce a more elegant version of democratic patienthood; a version that neither produces tokenistic practices of direct participation nor that denies patients the chance to contribute to matters where this may be truly meaningful.

5 January 2012 in Health Economics, Policy and Law
Verified
Journal Article
Closed access
PDF file
KVKarsten Vrangbaek
Karsten Vrangbaek
RRRuth Robertson
Ruth Robertson
UWUlrika Winblad
Ulrika Winblad
HBHester Van de Bovenkamp
Hester Van de Bovenkamp
ADAnna Dixon
Anna Dixon
This paper compares the introduction of policies to promote or strengthen patient choice in four Northern European countries – Denmark, England, the Netherlands and Sweden. The paper examines whether there has been convergence in choice policies across Northern Europe. Following Christopher Pollitt's suggestion, the paper distinguishes between rhetorical (discursive) convergence, decision (design) convergence and implementation (operational) convergence (Pollitt, 2002). This leads to the following research question for the article: Is the introduction of policies to strengthen choice in the four countries characterised by discursive, decision and operational convergence? The paper concludes that there seems to be convergence among these four countries in the overall policy rhetoric about the objectives associated with patient choice, embracing both concepts of empowerment (the intrinsic value) and market competition (the instrumental value). It appears that the institutional context and policy concerns such as waiting times have been important in affecting the timing of the introduction of choice policies and implementation, but less so in the design of choice policies. An analysis of the impact of choice policies is beyond the scope of this paper, but it is concluded that further research should investigate how the institutional context and timing of implementation affect differences in how the choice policy works out in practice.

10 October 2013 in Public Administration
Verified
Journal Article
Closed access
PDF file
VBVAN DE Bovenkamp
VAN DE Bovenkamp
HMHester M.
Hester M.
MMMarleen DE Mul
Marleen DE Mul
JQJulia G.U. Quartz
Julia G.U. Quartz
JWJ.W.M. Weggelaar‐Jansen
J.W.M. Weggelaar‐Jansen
RBRoland Bal
Roland Bal